C1QTNF9 and myocardial infarction: In our previous study, CTRP9 was administered from 4 h to 6 weeks after MI surgery, and found that mice received CTRP9 supplementation had smaller infarct size, confirming that early intervention of CTRP9 after MI reduces acute cardiac dysfunction and protects damaged myocardium.14